Abbott: Thrombosis trials

The registry lists 11 Thrombosis studies with Abbott as lead sponsor. 0 are open to participants now and 8 have results posted.

Phase 3 1Phase 4 3No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• JETi Lower Extremity Arterial ThrombosisCompletedNCT04370691Results posted
• XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm StudyCompletedNCT01894152Results posted
• XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm StudyCompletedNCT01249027Results posted
• EXCEL Clinical TrialCompletedNCT01205776Not applicableResults posted
• XIENCE V: SPIRIT WOMEN Sub-studyCompletedNCT01182428Phase 4Results posted
• XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)CompletedNCT01178268Phase 4Results posted
• XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for JapanCompletedNCT01086228Results posted
• SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)CompletedNCT00180479Phase 3Results posted
• PREVENtion of HeartMate II Pump ThrombosisCompletedNCT02158403Not applicable
• EXCEL Clinical Trial (Universal Registry)CompletedNCT01205789
• XIENCE V: SPIRIT WOMENCompletedNCT00496938Phase 4